BioCorRx Pharmaceuticals Inc a subsidiary of BioCorRx Inc (OTCQB: BICX)

Pharmaceutical ManufacturingCalifornia, United States2-10 Employees

BioCorRx Pharmaceuticals Inc., a subsidiary of BioCorRx Inc. (OTCQB: BICX), is a clinical-stage and commercial biopharmaceutical company devoted to creating meaningful change for individuals and families affected by addiction and related conditions. Our focus is on developing products to treat opioid use disorder and alcohol use disorder that support long-term recovery and wellness.

Our lead candidate, BICX104, is an implantable, sustained-release formulation of naltrexone thoughtfully designed to help improve patient adherence and reduce the risk of relapse — offering a path toward greater stability, hope, and healing. We are working diligently to advance BICX104 toward future U.S. Food and Drug Administration (FDA) approval, driven by our deep commitment to improving lives.

As of 2025, BioCorRx Pharmaceuticals Inc. has taken an important step forward by expanding its portfolio through the acquisition of a commercialized, FDA-approved drug. This milestone marks our evolution from a development-stage company to one that is now generating revenue — a testament to our dedication to both innovation and compassion in healthcare.

For more information, please visit biocorrx.com/rd

Sign up for free to view info

Email Format Employee directory